NCT03054194View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 2, 2017

Study Completion Date

March 2, 2017

Conditions
Healthy Participants
Interventions
DRUG

E2730

capsules

DRUG

Placebo

capsules

Trial Locations (1)

78217

Eisai Trial Site, San Antonio

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT03054194 - Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 | Biotech Hunter | Biotech Hunter